Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Diseases

Explore clinical trials studying Gastrointestinal Diseases. Study availability and eligibility vary by location and protocol.

18,009 public trials 3,508 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Diseases trial results

Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

NCT06997497

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +12 more
Locations
  • Los Angeles Hematology Oncology Medical Group ( Site 0084) Los Angeles, California, United States
  • Orlando Health Cancer Institute ( Site 0065) Orlando, Florida, United States
  • University of Iowa ( Site 0074) Iowa City, Iowa, United States
  • University of Kentucky ( Site 0055) Lexington, Kentucky, United States
View all 236 locations
View Trial Details
Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Koto Ku, Tokyo, Japan
View all 17 locations
View Trial Details
Recruiting

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

NCT07525206

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Astera Cancer Care /ID# 279532 East Brunswick, New Jersey, United States
  • Northwell Health Center for Advanced Medicine. /ID# 279590 Lake Success, New York, United States
  • Compass Oncology - Rose Quarter /ID# 280127 Portland, Oregon, United States
  • University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451 Seattle, Washington, United States
View all 62 locations
View Trial Details
Recruiting

Aquarius Pilot Study to Evaluate the New Axonics Trial System

NCT07335484

Conditions
Digestive System Diseases, Fecal Incontinence, Fecal Incontinence (FI), +20 more
Locations
  • Calvary North Adelaide Hospital/Better Bladders North Adelaide, South Australia, Australia
  • Epworth Freemasons Hospital East Melbourne, Victoria, Australia
  • Southern Urogynecology West Columbia, South Carolina, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

NCT07221357

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Local Institution - 0428 Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center Orange, California, United States
View all 285 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT06430801

Conditions
Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
Locations
  • Digestive Health Specialists ( Site 5064) Dothan, Alabama, United States
  • Arizona Arthritis & Rheumatology Research, PC ( Site 5094) Phoenix, Arizona, United States
  • GI Alliance - Sun City ( Site 5118) Sun City, Arizona, United States
  • University of Arizona Clinical and Translational Sciences Research Center ( Site 5111) Tucson, Arizona, United States
View all 499 locations
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

NCT06820463

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • City of Hope National Medical Center /ID# 270255 Duarte, California, United States
  • UCLA - Santa Monica /ID# 270621 Santa Monica, California, United States
  • Yale New Haven Hospital /ID# 270565 New Haven, Connecticut, United States
  • University of Chicago Medical Center /ID# 271688 Chicago, Illinois, United States
View all 71 locations
View Trial Details

Related conditions